Targeting the alternative bile acid synthetic pathway for metabolic diseases

Keyphrases

• Alternative Pathway 50%
• Bile Acid Composition 25%
• Bile Acid Excretion 25%
• Bile Acid Metabolism 75%
• Bile Acid Receptor 25%
• Bile Acid Signaling 25%
• Bile Acids 100%
• Chenodeoxycholic Acid 25%
• Cholesterol Catabolism 25%
• Cholic Acid 25%
• Classical Pathway 25%
• Energy Expenditure 25%
• Fatty Liver Disease 25%
• Glucose Metabolism 25%
• Gut Microbiota 25%
• Hydroxylated 50%
• Hyperglycemia 25%
• Inflammation 25%
• Insulin Resistance 25%
• Lipid Catabolism 25%
• Lipid Homeostasis 25%
• Lipid Metabolism 25%
• Liver 25%
• Major Pathway 25%
• Membrane Receptors 25%
• Metabolic Disease 100%
• Multistep Reactions 25%
• Non-alcoholic Fatty Liver Disease (NAFLD) 25%
• Nuclear Receptor 25%
• Obesity 25%
• Oxysterols 25%
• Pharmacological Strategies 25%
• Primary Bile Acid 50%
• Receptor Signaling 25%
• Receptor-mediated 25%
• Signaling Molecules 25%
• Signaling Pathway 50%
• Synthetic Pathway 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Bile Acid 100%
• Cell Nucleus Receptor 10%
• Chenodeoxycholic Acid 10%
• Cholic Acid 10%
• Diseases 100%
• Fatty Liver 10%
• Hyperglycemia 10%
• Inflammation 10%
• Insulin Resistance 10%
• Intestine Flora 10%
• Membrane Receptor 10%
• Metabolic Disorder 10%
• Nonalcoholic Fatty Liver 10%
• Oxysterol 10%
• Receptor 10%

Biochemistry, Genetics and Molecular Biology

• Bile Acid 100%
• Bile Acid Metabolism 14%
• Bile Acid Synthesis 28%
• Chenodeoxycholic Acid 14%
• Cholic Acid 14%
• Energy Expenditure 14%
• Glucose Metabolism 14%
• Hyperglycemia 14%
• Insulin Resistance 14%
• Intestine Flora 14%
• Lipid Homeostasis 14%
• Lipid Metabolism 14%
• Lipolysis 14%
• Metabolic Disorder 14%
• Oxysterol 14%